Obligacje LLYCL
Poniżej znajduje się lista obligacji korporacyjnych ELI LILLY AND COMPANY. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|
 US532457AM0ELI LILLY 2025 | 5,71% | 101,38% | 7,13% | 2025-06-01 | 217,471 M USD | 1 000,00 USD | 5 000,00 USD | Eli Lilly & Co. |
| LLY4099975Eli Lilly and Company 4.65% 15-JUN-2044 | 5,39% | 90,48% | 4,65% | 2044-06-15 | 38,336 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871804Eli Lilly and Company 5.2% 14-AUG-2064 | 5,39% | 96,39% | 5,20% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5547405Eli Lilly and Company 4.95% 27-FEB-2063 | 5,31% | 93,18% | 4,95% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871803Eli Lilly and Company 5.05% 14-AUG-2054 | 5,30% | 95,81% | 5,05% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5547404Eli Lilly and Company 4.875% 27-FEB-2053 | 5,30% | 93,17% | 4,88% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750032Eli Lilly and Company 5.1% 09-FEB-2064 | 5,29% | 96,37% | 5,10% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY.GGEli Lilly and Company 6.77% 01-JAN-2036 | 5,24% | 113,25% | 6,77% | 2036-01-01 | 158,565 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. |
| LLY5750031Eli Lilly and Company 5.0% 09-FEB-2054 | 5,21% | 96,55% | 5,00% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BS6ELI LILLY 19/39 | 5,17% | 86,41% | 3,88% | 2039-03-15 | 240,253 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BT4ELI LILLY 19/49 | 5,13% | 82,27% | 3,95% | 2049-03-15 | 958,153 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BU1ELI LILLY 19/59 | 5,11% | 82,41% | 4,15% | 2059-03-15 | 591,286 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY4217068Eli Lilly and Company 3.7% 01-MAR-2045 | 5,10% | 81,27% | 3,70% | 2045-03-01 | 386,799 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY4492882Eli Lilly and Company 3.95% 15-MAY-2047 | 5,08% | 83,83% | 3,95% | 2047-05-15 | 346,952 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5547406Eli Lilly and Company 5.0% 27-FEB-2026 | 5,07% | 99,91% | 5,00% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| XS238628644ELI LILLY 21/43 | 5,04% | 56,29% | 1,63% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. |
| LLY.HWEli Lilly and Company 5.95% 15-NOV-2037 | 5,04% | 108,95% | 5,95% | 2037-11-15 | 266,828 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY.GWEli Lilly and Company 5.55% 15-MAR-2037 | 4,98% | 105,37% | 5,55% | 2037-03-15 | 444,732 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750405Eli Lilly and Company 4.7% 09-FEB-2034 | 4,96% | 98,01% | 4,70% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871807Eli Lilly and Company 4.6% 14-AUG-2034 | 4,96% | 97,20% | 4,60% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BY3ELI LILLY 20/50 | 4,87% | 58,72% | 2,25% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5546986Eli Lilly and Company 4.7% 27-FEB-2033 | 4,84% | 99,01% | 4,70% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BZ0ELI LILLY 20/60 | 4,76% | 56,29% | 2,50% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871810Eli Lilly and Company 4.2% 14-AUG-2029 | 4,54% | 98,51% | 4,20% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750404Eli Lilly and Company 4.5% 09-FEB-2029 | 4,51% | 99,95% | 4,50% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BV9ELI LILLY 19/29 | 4,51% | 95,49% | 3,38% | 2029-03-15 | 930,564 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750407Eli Lilly and Company 4.5% 09-FEB-2027 | 4,42% | 100,18% | 4,50% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871809Eli Lilly and Company 4.15% 14-AUG-2027 | 4,35% | 99,48% | 4,15% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY4492876Eli Lilly and Company 3.1% 15-MAY-2027 | 4,30% | 97,11% | 3,10% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY.GVEli Lilly and Company 5.5% 15-MAR-2027 | 4,19% | 102,95% | 5,50% | 2027-03-15 | 364,324 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLYCELI LILLY 15/25 | 3,99% | 98,78% | 2,75% | 2025-06-01 | 560,646 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| XS207593800ELI LILLY 19/49 | 3,27% | 72,14% | 1,70% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS238622069ELI LILLY 21/61 | 3,27% | 56,43% | 1,38% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS238618657ELI LILLY 21/51 | 3,20% | 61,02% | 1,13% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS238618606ELI LILLY 21/33 | 2,89% | 81,24% | 0,50% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS207593737ELI LILLY 19/31 | 2,88% | 85,67% | 0,63% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS124075122ELI LILLY 15/30 | 2,79% | 96,53% | 2,13% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| LLYFELI LILLY 15/26 | 2,64% | 98,43% | 1,63% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| CH32373560ELI LILLY 16-28 | 0,57% | 99,58% | 0,45% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. |